Laval University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Laval University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10700
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Laval University is an educational institute that offers medical education and research services. The institute provides undergraduate, postgraduate, degree programs and distance education programs. It offers courses in the fields of advanced international studies, agriculture and food sciences, arts and human sciences, business administration, dentistry and education. Laval University also provides courses in the fields of forestry, geography and geomatics, graduate and postdoctoral studies, law, medicine, music, nursing, pharmacy, philosophy, science and engineering, social sciences and theology and religious studies. The institute operates interdisciplinary institutes, research centers, international mixed units, mixed research unit and others. Laval University is headquartered in Quebec City, Quebec, Canada.

Laval University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laval University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laval University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Laval University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Laval University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
AmorChem Enters into Co-Development Agreement with Universite Laval and CHU De Quebec 10
Roche Enters Into Research Agreement With Laval University 11
AmorChem Enters Into Co-Development Agreement With Universite Laval And CHU De Quebec 12
Licensing Agreements 13
Signia Therapeutics Enters into Licensing Agreement with University Claude Bernard of Lyon and Laval University 13
Microlin Bio Enters into Licensing Agreement with Universite Laval 14
Raptor Pharma Enters Into Licensing Agreement With Universite Laval For IP Rights Related To Parkinson’s Disease 15
Laval University – Key Competitors 16
Laval University – Key Employees 17
Laval University – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Government and Public Interest 19
Feb 19, 2018: Government of Canada and Brain Canada announce a $10-million grant to establish a platform that will help researchers share data more widely and efficiently 19
Aug 21, 2017: The Government of Canada invests over $21M in innovative health research 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Laval University, Pharmaceuticals & Healthcare, Key Facts 2
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laval University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laval University, Deals By Therapy Area, 2012 to YTD 2018 8
Laval University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AmorChem Enters into Co-Development Agreement with Universite Laval and CHU De Quebec 10
Roche Enters Into Research Agreement With Laval University 11
AmorChem Enters Into Co-Development Agreement With Universite Laval And CHU De Quebec 12
Signia Therapeutics Enters into Licensing Agreement with University Claude Bernard of Lyon and Laval University 13
Microlin Bio Enters into Licensing Agreement with Universite Laval 14
Raptor Pharma Enters Into Licensing Agreement With Universite Laval For IP Rights Related To Parkinson's Disease 15
Laval University, Key Competitors 16
Laval University, Key Employees 17
Laval University, Subsidiaries 18

List of Figures
Laval University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Laval University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Laval University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Laval University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Laval University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Laval University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Keio University:製薬・医療:M&Aディール及び事業提携情報
    Summary Keio University (Keio) is an educational institution that offers education and research services. The institute provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the fields of law and economics, hum …
  • PFB Corp (PFB):企業の財務・戦略的SWOT分析
    Summary PFB Corp (PFB) is a diversified company. The company manufactures and distributes insulating building products and technologies. The company provides EPS product solutions such as insulspan structural insulating panel systems, rating system, insulated concrete forming system, timber framing …
  • Herbalife Nutrition Ltd (HLF):企業の財務・戦略的SWOT分析
    Herbalife Nutrition Ltd (HLF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Mitsubishi Motors Corporation (7211):企業の財務・戦略的SWOT分析
    Mitsubishi Motors Corporation (7211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • CenterPoint Energy Inc (CNP):電力:M&Aディール及び事業提携情報
    Summary CenterPoint Energy Inc (CenterPoint) is an energy utility company that carries out electric transmission and distribution, and natural gas distribution. It is also involved in natural gas sales and service, pipeline services and other field services. The company sells regulated intrastate na …
  • Grupo Nutresa SA (NUTRESA):企業の財務・戦略的SWOT分析
    Grupo Nutresa SA (NUTRESA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Akonni Biosystems Inc-医療機器分野:企業M&A・提携分析
    Summary Akonni Biosystems Inc (Akonni Biosystems) is a molecular diagnostics company that develops, manufactures, and distributes integrated molecular diagnostic systems. The company’s products include nucleic acid extraction kits, molecular diagnostic tests, thermal cyclers, microarray readers and …
  • EQT Corp (EQT):企業の財務・戦略的SWOT分析
    EQT Corp (EQT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Shanghai SECCO Petrochemical Co Ltd:企業の戦略的SWOT分析
    Shanghai SECCO Petrochemical Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • PT Hanjaya Mandala Sampoerna Tbk. (HMSP):企業の財務・戦略的SWOT分析
    PT Hanjaya Mandala Sampoerna Tbk. (HMSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Hormel Foods Corp:企業の戦略・SWOT・財務情報
    Hormel Foods Corp - Strategy, SWOT and Corporate Finance Report Summary Hormel Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Baloise Belgium NV:企業の戦略・SWOT・財務分析
    Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report Summary Baloise Belgium NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Sun Resources NL (SUR):石油・ガス:M&Aディール及び事業提携情報
    Summary Sun Resources NL (Sun Resources) is an oil and gas exploration and development company. The company explores and develops crude oil and natural gas. Its services include exploration, production, and development of unconventional oil and gas resources. Its projects include Delta Oil Project, …
  • Holidaybreak Ltd:企業の戦略・SWOT・財務情報
    Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report Summary Holidaybreak Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • HORNBACH-Baumarkt-AG (HBM):企業の財務・戦略的SWOT分析
    HORNBACH-Baumarkt-AG (HBM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Alder Biopharmaceuticals Inc (ALDR):企業の財務・戦略的SWOT分析
    Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Intrinsic Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intrinsic Therapeutics Inc (Intrinsic) is a medical device company that develops medical devices for the treatment of lumbar disc herniations. The company offers prosthesis for partial anulus replacement following discectomy surgery, prosthesis for partial anulus replacement, and anular clos …
  • Centric Health Corp (CHH):企業の財務・戦略的SWOT分析
    Summary Centric Health Corp (CHC) is a healthcare and wellness service provider. The company operates through specialty pharmacy, orthotics, and surgical and medical centres. Its pharmacies provide traditional pharmacy services such as compounding and dispensing medications, and clinical and special …
  • Aeras Global TB Vaccine Foundation Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aeras Global TB Vaccine Foundation Inc (Aeras) is a non-profit biotech organization that develops tuberculosis (TB) vaccines. The organization offers TB vaccine candidates, preclinical candidates and vaccine candidates. Its services include portfolio management, preclinical research, clinica …
  • Duvel Moortgat NV:企業の戦略的SWOT分析
    Duvel Moortgat NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆